Showing results (131-140 of 182) with videos related to
Sort By:
Pageof 19
Future Medicinal Chemistry|November 13, 2023
Discovery of new VEGFR-2 inhibitors and apoptosis inducer-based thieno[2,3-d]pyrimidineSouad A El-Metwally, Hazem Elkady, Mohamed Hagras, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|August 18, 2022
Anti-cancer and immunomodulatory evaluation of new nicotinamide derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: in vitro and in silico studiesReda G Yousef, Alaa Elwan, Ibraheem M M Gobaara, et al.ACS Omega|September 5, 2022
Synthesis of Novel 2,3-Dihydro-1,5-Benzothiazepines as α-Glucosidase Inhibitors: In Vitro, In Vivo, Kinetic, SAR, Molecular Docking, and QSAR StudiesRabia Mehmood, Ehsan Ullah Mughal, Eslam B Elkaeed, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|December 20, 2021
2-Arylquinolines as novel anticancer agents with dual EGFR/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insightsMostafa M Elbadawi, Wagdy M Eldehna, Amer Ali Abd El-Hafeez, et al.Molecular Diversity|May 10, 2023
New apoptotic anti-triple-negative breast cancer theobromine derivative inhibiting EGFRWT and EGFRT790M: in silico and in vitro evaluationIbrahim H Eissa, Reda G Yousef, Hazem Elkady, et al.Future Medicinal Chemistry|May 8, 2025
Development of new anticancer thiadiazole-sulfonamides as dual EGFR/carbonic anhydrase inhibitorsIbrahim H Eissa, Hazem Elkady, Walid E Elgammal, et al.Bioorganic Chemistry|January 23, 2024
Identification of new anti-mycobacterial agents based on quinoline-isatin hybrids targeting enoyl acyl carrier protein reductase (InhA)Eman F Khaleel, Ahmed Sabt, Malgorzata Korycka-Machala, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|July 25, 2022
Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, in silico studies, and antiproliferative evaluationMohammed S Taghour, Hazem A Mahdy, Maher H Gomaa, et al.Plos One|September 4, 2025
A novel sulfamoylphenyl-dihydro-thiadiazole derivative as a dual EGFR and carbonic anhydrase inhibitor for cancer therapyIbrahim H Eissa, Hazem Elkady, Walid E Elgammal, et al.Molecules (Basel, Switzerland)|August 12, 2022
Modified Benzoxazole-Based VEGFR-2 Inhibitors and Apoptosis Inducers: Design, Synthesis, and Anti-Proliferative EvaluationAlaa Elwan, Abdallah E Abdallah, Hazem A Mahdy, et al.Pageof 19